GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuroscientific Biopharmaceuticals Ltd (ASX:NSB) » Definitions » PEG Ratio
中文

Neuroscientific Biopharmaceuticals (ASX:NSB) PEG Ratio

: N/A (As of Today)
View and export this data going back to 2018. Start your Free Trial
PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Neuroscientific Biopharmaceuticals's PE Ratio without NRI is 10.60. Neuroscientific Biopharmaceuticals's 5-Year EBITDA growth rate is 0.00%. Therefore, Neuroscientific Biopharmaceuticals's PEG Ratio for today is N/A.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Neuroscientific Biopharmaceuticals's PEG Ratio or its related term are showing as below:



ASX:NSB's PEG Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 1.435
* Ranked among companies with meaningful PEG Ratio only.

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Neuroscientific Biopharmaceuticals PEG Ratio Historical Data

The historical data trend for Neuroscientific Biopharmaceuticals's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuroscientific Biopharmaceuticals Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
PEG Ratio
- - - - -

Neuroscientific Biopharmaceuticals Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Biotechnology subindustry, Neuroscientific Biopharmaceuticals's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuroscientific Biopharmaceuticals PEG Ratio Distribution

For the Biotechnology industry and Healthcare sector, Neuroscientific Biopharmaceuticals's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Neuroscientific Biopharmaceuticals's PEG Ratio falls into.



Neuroscientific Biopharmaceuticals PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Neuroscientific Biopharmaceuticals's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=10.6/0.00
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Neuroscientific Biopharmaceuticals  (ASX:NSB) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Neuroscientific Biopharmaceuticals PEG Ratio Related Terms

Thank you for viewing the detailed overview of Neuroscientific Biopharmaceuticals's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Neuroscientific Biopharmaceuticals (ASX:NSB) Business Description

Traded in Other Exchanges
N/A
Address
85 Forrest Street, Suite 5, Cottesloe, Perth, WA, AUS, 6011
Neuroscientific Biopharmaceuticals Ltd is an Australian-based biotechnology company. The company is engaged in the development of diagnostic and therapeutic treatments for neurodegenerative diseases through preclinical studies of patented technologies.

Neuroscientific Biopharmaceuticals (ASX:NSB) Headlines

No Headlines